Found 19 Multiple Myeloma trials
A listing of Multiple Myeloma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The purpose of this study is to learn how participant factors (such as medical history and manufacturing starting material, also known as Apheresis) can predict successful manufacturing of ciltacabtagene autoleucel (Cilta-cel). This information can be used to potentially improve manufacturing processes and treat more patients with Cilta-cel. We would like …
Please refer to the protocol, Section 2 (Objectives and Endpoints) Please refer to the protocol, Section 2 (Objectives and Endpoints) Please refer to the protocol, Section 2 (Objectives and Endpoints)
Please refer to the Protocol, Section 3.1 (Objectives) Please refer to the Protocol, Section 3 (Objectives and Endpoints) Please refer to the Protocol, Section 3 (Objectives and Endpoints)
The purpose of this study is to see if using talquetamab either before or after ciltacabtagene autoleucel is safe and useful for treating patients with multiple myeloma. We would like to rely on Sterling IRB as the IRB of record for this study.
Please refer to Protocol Section 3 (Objectives and Endpoints). Please refer to Protocol Section3 (Objectives and Endpoints). Please refer to Protocol Section3 (Objectives and Endpoints).
The purpose of this study is to test the safety and tolerability of KTX-1001 in patients with Relapsed and Refractory Multiple Myeloma. We would like to rely on Advarra as the IRB of record.
The purpose of this study is to compare the efficacy, safety, and tolerability of ide-cel with lenalidomide (LEN) maintenance to that of LEN maintenance alone in adult participants with Newly Diagnosed Multiple Myeloma (NDMM) who have achieved a suboptimal response post autologous stem cell transplantation (ASCT). We would like to …
The research study is being conducted to understand the effects of tasquinimod, an experimental medication, on patients with myeloma. Eligibile subject have multiple myeloma that has been previously treated and is now in need of additional treatment. Part 1 of this study evaluates tasquinimod alone. Part 2 of this study …
The purpose of this study is to compare the efficacy of teclistamab with PVd/Kd in multiple myeloma patients.
11 - 19 of 19
- 1
- 2
